📊 Score Breakdown
Offering Ability
30
Cash Runway
0
Float Risk
35
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
☀️
Clear
No significant dilution signals
9%
💰 Capital Raise
18%
• Active ATM program with $100M remaining capacity
💹 Market Data
Market Cap$926.10M
Shares Outstanding92.61M
Float52.33M
Cash$71.54M
Debt$87.53M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↑ 1.1% shares (2025Q4 vs prior)
129 institutional holders · 65.52M shares
#1
Sanofi
12.20M shares
#2
PERCEPTIVE ADVISORS LLC
10.33M shares
#3
JOHNSON & JOHNSON
6.64M shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest5.73M
Days to Cover4.3
% of Float10.9%
FINRA data as of Apr 30, 2026
📁 Recent SEC Activity
xbrl
XBRL WARRANT
Dec 31, 2018
xbrl
XBRL CONVERTIBLE
Dec 31, 2018
4
INSIDER TRANSACTION
Apr 23, 2026
4
INSIDER TRANSACTION
Apr 21, 2026
424B5
ATM
Apr 16, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for MGTX
📊 MGTX FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 MGTX Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.